TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2011

A phase II study of biweekly mitomycin C and irinotecan combination therapy in patients with fluoropyrimidine-resistant advanced gastric cancer: a report from the Gastrointestinal Oncology Group of the Japan Clinical Oncology Group (JCOG0109-DI Trial).

Tetsuya Hamaguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.